JPG77 Sunday, 07/26/20 07:39:44 PM Re: None Post # of 150062 LERONLIMAB PATIENTS HAD 63% LESS SERIOUS ADVERSE EVENTS THAN CONTROL SUBJECTS IN MILD-TO-MODERATE PATIENTS My comments are just my opinions and should NOT be taken as investment advice.